Company / Shareholders' Equity
Outset Medical, Inc. Shareholders' Equity History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$26.8M
FY2025
5-year range
-$372.2M / $374.1M
FY2021-FY2025
Trend
-89.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $374M to $27M over the past 2 years.
Based on SEC 10-K filings.
$27M in FY2025 with a 3-year CAGR of -56.6%.
Declined from $374M to $27M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -56.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -56.6%, indicating a declining trend.
- In FY2025, shareholders' equity decreased 89.1% year-over-year.
- Peak shareholders' equity was recorded in FY2023.
- Lowest shareholders' equity in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.88 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $26.8M | -89.1% |
| FY2024 | $246.0M | -34.2% |
| FY2023 | $374.1M | +13.8% |
| FY2022 | $328.6M | +188.3% |
| FY2021 | -$372.2M | -29.3% |
| FY2020 | -$287.9M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026